GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CSPCY) » Definitions » Price-to-Operating-Cash-Flow

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Price-to-Operating-Cash-Flow : (As of May. 06, 2024)


View and export this data going back to 2018. Start your Free Trial

What is CSPC Pharmaceutical Group Price-to-Operating-Cash-Flow?

As of today (2024-05-06), CSPC Pharmaceutical Group's share price is $3.406. CSPC Pharmaceutical Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Hence, CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

CSPCY' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.57   Med: 22.24   Max: 56.67
Current: 17.39

During the past 13 years, CSPC Pharmaceutical Group's highest Price-to-Operating-Cash-Flow Ratio was 56.67. The lowest was 7.57. And the median was 22.24.

CSPCY's Price-to-Operating-Cash-Flow is ranked better than
50.59% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.64 vs CSPCY: 17.39

CSPC Pharmaceutical Group's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of CSPC Pharmaceutical Group was -46.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -16.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 19.10% per year.

During the past 13 years, CSPC Pharmaceutical Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 100.90% per year. The lowest was -59.50% per year. And the median was 21.40% per year.


CSPC Pharmaceutical Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Price-to-Operating-Cash-Flow Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.50 11.90 17.83 11.47 18.86

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.47 - - - 18.86

Competitive Comparison of CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow falls into.



CSPC Pharmaceutical Group Price-to-Operating-Cash-Flow Calculation

CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=3.406/0
=

CSPC Pharmaceutical Group's Share Price of today is $3.406.
CSPC Pharmaceutical Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

CSPC Pharmaceutical Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Headlines

From GuruFocus

Value Partners Classic Fund Comments on CSPC Pharmaceutical

By Vera Yuan Vera Yuan 07-29-2014